Eulerpool Terminal
The edge that pays for itself.
Current Sutro Biopharma forecasts and price targets in July 2026
Ø Analyst Price Targets
34.53 USD
+45.65 %
Median
20.40 USD
-13.96 %
Max
105.00 USD
Min
8.08 USD
Last Price
23.71 USD
Buy
11
Hold
4
Sell
1
The average target price for Sutro Biopharma is 34.53 USD. (+45.65 % above the current price)
The median price target of Sutro Biopharma is 20.40 USD.
Stock analysts from many renowned investment banks are closely examining the Sutro Biopharma stock. They conclude their professional Sutro Biopharma stock analyses with a clear recommendation for the Sutro Biopharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 11 | 4 | 1 | 34.53 USD |
| 2026-01-01 | 10 | 5 | 1 | 34.53 USD |
| 2025-12-01 | 10 | 5 | 1 | 35.99 USD |
| 2025-12-01 | 10 | 5 | 1 | 39.05 USD |
| 2025-11-01 | 10 | 5 | 1 | 2.74 USD |
| 2025-11-01 | 10 | 5 | 1 | 2.74 USD |
Sutro Biopharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Sutro Biopharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 44.00 M USD | -72.00 M USD | -8.39 USD |
| 2027e | 34.00 M USD | -62.00 M USD | -7.22 USD |
| 2028e | 42.00 M USD | -61.00 M USD | -7.11 USD |